1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Prostate Specific Antigen Test (PSA) 1.2.3 Digital Rectal Exam (DRE) 1.3 Market by Application 1.3.1 Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Diagnostic clinics 1.3.4 Research centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prostate Cancer Diagnosis and Treatment Market Perspective (2016-2027) 2.2 Prostate Cancer Diagnosis and Treatment Growth Trends by Regions 2.2.1 Prostate Cancer Diagnosis and Treatment Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Prostate Cancer Diagnosis and Treatment Historic Market Share by Regions (2016-2021) 2.2.3 Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027) 2.3 Prostate Cancer Diagnosis and Treatment Industry Dynamic 2.3.1 Prostate Cancer Diagnosis and Treatment Market Trends 2.3.2 Prostate Cancer Diagnosis and Treatment Market Drivers 2.3.3 Prostate Cancer Diagnosis and Treatment Market Challenges 2.3.4 Prostate Cancer Diagnosis and Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue 3.1.1 Global Top Prostate Cancer Diagnosis and Treatment Players by Revenue (2016-2021) 3.1.2 Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Players (2016-2021) 3.2 Global Prostate Cancer Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Prostate Cancer Diagnosis and Treatment Revenue 3.4 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio 3.4.1 Global Prostate Cancer Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnosis and Treatment Revenue in 2020 3.5 Prostate Cancer Diagnosis and Treatment Key Players Head office and Area Served 3.6 Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service 3.7 Date of Enter into Prostate Cancer Diagnosis and Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prostate Cancer Diagnosis and Treatment Breakdown Data by Type 4.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Type (2016-2021) 4.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2022-2027) 5 Prostate Cancer Diagnosis and Treatment Breakdown Data by Application 5.1 Global Prostate Cancer Diagnosis and Treatment Historic Market Size by Application (2016-2021) 5.2 Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Prostate Cancer Diagnosis and Treatment Market Size (2016-2027) 6.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Type 6.2.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) 6.2.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) 6.2.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027) 6.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Application 6.3.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) 6.3.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) 6.3.3 North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027) 6.4 North America Prostate Cancer Diagnosis and Treatment Market Size by Country 6.4.1 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) 6.4.2 North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Prostate Cancer Diagnosis and Treatment Market Size (2016-2027) 7.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type 7.2.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) 7.2.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) 7.2.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027) 7.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application 7.3.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) 7.3.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) 7.3.3 Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027) 7.4 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country 7.4.1 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) 7.4.2 Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size (2016-2027) 8.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type 8.2.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027) 8.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application 8.3.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027) 8.4 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region 8.4.1 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size (2016-2027) 9.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type 9.2.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) 9.2.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) 9.2.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027) 9.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application 9.3.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) 9.3.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) 9.3.3 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027) 9.4 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country 9.4.1 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) 9.4.2 Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size (2016-2027) 10.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type 10.2.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2027) 10.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application 10.3.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2027) 10.4 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country 10.4.1 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Introduction 11.1.4 Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 AbbVie 11.2.1 AbbVie Company Details 11.2.2 AbbVie Business Overview 11.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Introduction 11.2.4 AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.2.5 AbbVie Recent Development 11.3 Active Biotech 11.3.1 Active Biotech Company Details 11.3.2 Active Biotech Business Overview 11.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Introduction 11.3.4 Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.3.5 Active Biotech Recent Development 11.4 Amgen 11.4.1 Amgen Company Details 11.4.2 Amgen Business Overview 11.4.3 Amgen Prostate Cancer Diagnosis and Treatment Introduction 11.4.4 Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.4.5 Amgen Recent Development 11.5 Astellas Pharma 11.5.1 Astellas Pharma Company Details 11.5.2 Astellas Pharma Business Overview 11.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Introduction 11.5.4 Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.5.5 Astellas Pharma Recent Development 11.6 AstraZeneca 11.6.1 AstraZeneca Company Details 11.6.2 AstraZeneca Business Overview 11.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Introduction 11.6.4 AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.6.5 AstraZeneca Recent Development 11.7 Bavarian Nordic 11.7.1 Bavarian Nordic Company Details 11.7.2 Bavarian Nordic Business Overview 11.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Introduction 11.7.4 Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.7.5 Bavarian Nordic Recent Development 11.8 Bayer 11.8.1 Bayer Company Details 11.8.2 Bayer Business Overview 11.8.3 Bayer Prostate Cancer Diagnosis and Treatment Introduction 11.8.4 Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.8.5 Bayer Recent Development 11.9 Bristol-Myers Squibb 11.9.1 Bristol-Myers Squibb Company Details 11.9.2 Bristol-Myers Squibb Business Overview 11.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Introduction 11.9.4 Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.9.5 Bristol-Myers Squibb Recent Development 11.10 Dendreon 11.10.1 Dendreon Company Details 11.10.2 Dendreon Business Overview 11.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Introduction 11.10.4 Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.10.5 Dendreon Recent Development 11.11 Endo 11.11.1 Endo Company Details 11.11.2 Endo Business Overview 11.11.3 Endo Prostate Cancer Diagnosis and Treatment Introduction 11.11.4 Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.11.5 Endo Recent Development 11.12 Ferring Pharmaceuticals 11.12.1 Ferring Pharmaceuticals Company Details 11.12.2 Ferring Pharmaceuticals Business Overview 11.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction 11.12.4 Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.12.5 Ferring Pharmaceuticals Recent Development 11.13 GE Healthcare 11.13.1 GE Healthcare Company Details 11.13.2 GE Healthcare Business Overview 11.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Introduction 11.13.4 GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.13.5 GE Healthcare Recent Development 11.14 GSK 11.14.1 GSK Company Details 11.14.2 GSK Business Overview 11.14.3 GSK Prostate Cancer Diagnosis and Treatment Introduction 11.14.4 GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.14.5 GSK Recent Development 11.15 Ipsen 11.15.1 Ipsen Company Details 11.15.2 Ipsen Business Overview 11.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Introduction 11.15.4 Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.15.5 Ipsen Recent Development 11.16 Johnson & Johnson 11.16.1 Johnson & Johnson Company Details 11.16.2 Johnson & Johnson Business Overview 11.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Introduction 11.16.4 Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.16.5 Johnson & Johnson Recent Development 11.17 Pfizer 11.17.1 Pfizer Company Details 11.17.2 Pfizer Business Overview 11.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Introduction 11.17.4 Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.17.5 Pfizer Recent Development 11.18 Sanofi 11.18.1 Sanofi Company Details 11.18.2 Sanofi Business Overview 11.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Introduction 11.18.4 Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.18.5 Sanofi Recent Development 11.18 Siemens Healthineers .1 Siemens Healthineers Company Details .2 Siemens Healthineers Business Overview .3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Introduction .4 Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) .5 Siemens Healthineers Recent Development 11.20 Takeda 11.20.1 Takeda Company Details 11.20.2 Takeda Business Overview 11.20.3 Takeda Prostate Cancer Diagnosis and Treatment Introduction 11.20.4 Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.20.5 Takeda Recent Development 11.21 Teva Pharmaceutical 11.21.1 Teva Pharmaceutical Company Details 11.21.2 Teva Pharmaceutical Business Overview 11.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Introduction 11.21.4 Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.21.5 Teva Pharmaceutical Recent Development 11.22 Tolmar Pharmaceuticals 11.22.1 Tolmar Pharmaceuticals Company Details 11.22.2 Tolmar Pharmaceuticals Business Overview 11.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Introduction 11.22.4 Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) 11.22.5 Tolmar Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Prostate Cancer Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Prostate Specific Antigen Test (PSA) Table 3. Key Players of Digital Rectal Exam (DRE) Table 4. Global Prostate Cancer Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Prostate Cancer Diagnosis and Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Prostate Cancer Diagnosis and Treatment Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2016-2021) Table 8. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2022-2027) Table 10. Prostate Cancer Diagnosis and Treatment Market Trends Table 11. Prostate Cancer Diagnosis and Treatment Market Drivers Table 12. Prostate Cancer Diagnosis and Treatment Market Challenges Table 13. Prostate Cancer Diagnosis and Treatment Market Restraints Table 14. Global Prostate Cancer Diagnosis and Treatment Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Prostate Cancer Diagnosis and Treatment Market Share by Players (2016-2021) Table 16. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2020) Table 17. Ranking of Global Top Prostate Cancer Diagnosis and Treatment Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Prostate Cancer Diagnosis and Treatment Product Solution and Service Table 21. Date of Enter into Prostate Cancer Diagnosis and Treatment Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million) Table 24. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2016-2021) Table 25. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Prostate Cancer Diagnosis and Treatment Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2016-2021) Table 29. Global Prostate Cancer Diagnosis and Treatment Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million) Table 32. North America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million) Table 34. North America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size by Country (2022-2027) & (US$ Million) Table 61. Abbott Laboratories Company Details Table 62. Abbott Laboratories Business Overview Table 63. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product Table 64. Abbott Laboratories Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 65. Abbott Laboratories Recent Development Table 66. AbbVie Company Details Table 67. AbbVie Business Overview Table 68. AbbVie Prostate Cancer Diagnosis and Treatment Product Table 69. AbbVie Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 70. AbbVie Recent Development Table 71. Active Biotech Company Details Table 72. Active Biotech Business Overview Table 73. Active Biotech Prostate Cancer Diagnosis and Treatment Product Table 74. Active Biotech Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 75. Active Biotech Recent Development Table 76. Amgen Company Details Table 77. Amgen Business Overview Table 78. Amgen Prostate Cancer Diagnosis and Treatment Product Table 79. Amgen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 80. Amgen Recent Development Table 81. Astellas Pharma Company Details Table 82. Astellas Pharma Business Overview Table 83. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product Table 84. Astellas Pharma Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 85. Astellas Pharma Recent Development Table 86. AstraZeneca Company Details Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Prostate Cancer Diagnosis and Treatment Product Table 89. AstraZeneca Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 90. AstraZeneca Recent Development Table 91. Bavarian Nordic Company Details Table 92. Bavarian Nordic Business Overview Table 93. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product Table 94. Bavarian Nordic Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 95. Bavarian Nordic Recent Development Table 96. Bayer Company Details Table 97. Bayer Business Overview Table 98. Bayer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 99. Bayer Recent Development Table 100. Bristol-Myers Squibb Company Details Table 101. Bristol-Myers Squibb Business Overview Table 102. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product Table 103. Bristol-Myers Squibb Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 104. Bristol-Myers Squibb Recent Development Table 105. Dendreon Company Details Table 106. Dendreon Business Overview Table 107. Dendreon Prostate Cancer Diagnosis and Treatment Product Table 108. Dendreon Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 109. Dendreon Recent Development Table 110. Endo Company Details Table 111. Endo Business Overview Table 112. Endo Prostate Cancer Diagnosis and Treatment Product Table 113. Endo Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 114. Endo Recent Development Table 115. Ferring Pharmaceuticals Company Details Table 116. Ferring Pharmaceuticals Business Overview Table 117. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Table 118. Ferring Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 119. Ferring Pharmaceuticals Recent Development Table 120. GE Healthcare Company Details Table 121. GE Healthcare Business Overview Table 122. GE Healthcare Prostate Cancer Diagnosis and Treatment Product Table 123. GE Healthcare Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 124. GE Healthcare Recent Development Table 125. GSK Company Details Table 126. GSK Business Overview Table 127. GSK Prostate Cancer Diagnosis and Treatment Product Table 128. GSK Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 129. GSK Recent Development Table 130. Ipsen Company Details Table 131. Ipsen Business Overview Table 132. Ipsen Prostate Cancer Diagnosis and Treatment Product Table 133. Ipsen Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 134. Ipsen Recent Development Table 135. Johnson & Johnson Company Details Table 136. Johnson & Johnson Business Overview Table 137. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product Table 138. Johnson & Johnson Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 139. Johnson & Johnson Recent Development Table 140. Pfizer Company Details Table 141. Pfizer Business Overview Table 142. Pfizer Prostate Cancer Diagnosis and Treatment Product Table 143. Pfizer Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 144. Pfizer Recent Development Table 145. Sanofi Company Details Table 146. Sanofi Business Overview Table 147. Sanofi Prostate Cancer Diagnosis and Treatment Product Table 148. Sanofi Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 149. Sanofi Recent Development Table 150. Siemens Healthineers Company Details Table 151. Siemens Healthineers Business Overview Table 152. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product Table 153. Siemens Healthineers Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 154. Siemens Healthineers Recent Development Table 155. Takeda Company Details Table 156. Takeda Business Overview Table 157. Takeda Prostate Cancer Diagnosis and Treatment Product Table 158. Takeda Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 159. Takeda Recent Development Table 160. Teva Pharmaceutical Company Details Table 161. Teva Pharmaceutical Business Overview Table 162. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product Table 163. Teva Pharmaceutical Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 164. Teva Pharmaceutical Recent Development Table 165. Tolmar Pharmaceuticals Company Details Table 166. Tolmar Pharmaceuticals Business Overview Table 167. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Table 168. Tolmar Pharmaceuticals Revenue in Prostate Cancer Diagnosis and Treatment Business (2016-2021) & (US$ Million) Table 169. Tolmar Pharmaceuticals Recent Development Table 170. Research Programs/Design for This Report Table 171. Key Data Information from Secondary Sources Table 172. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate Cancer Diagnosis and Treatment Market Share by Type: 2020 VS 2027 Figure 2. Prostate Specific Antigen Test (PSA) Features Figure 3. Digital Rectal Exam (DRE) Features Figure 4. Global Prostate Cancer Diagnosis and Treatment Market Share by Application: 2020 VS 2027 Figure 5. Hospitals Case Studies Figure 6. Diagnostic clinics Case Studies Figure 7. Research centers Case Studies Figure 8. Prostate Cancer Diagnosis and Treatment Report Years Considered Figure 9. Global Prostate Cancer Diagnosis and Treatment Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Prostate Cancer Diagnosis and Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions: 2020 VS 2027 Figure 12. Global Prostate Cancer Diagnosis and Treatment Market Share by Regions (2022-2027) Figure 13. Global Prostate Cancer Diagnosis and Treatment Market Share by Players in 2020 Figure 14. Global Top Prostate Cancer Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Diagnosis and Treatment as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue in 2020 Figure 16. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2016-2021) Figure 17. Global Prostate Cancer Diagnosis and Treatment Revenue Market Share by Type (2022-2027) Figure 18. North America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027) Figure 20. North America Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027) Figure 21. North America Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027) Figure 22. United States Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027) Figure 26. Europe Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027) Figure 27. Europe Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027) Figure 28. Germany Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027) Figure 36. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027) Figure 37. Asia-Pacific Prostate Cancer Diagnosis and Treatment Market Share by Region (2016-2027) Figure 38. China Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027) Figure 46. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027) Figure 47. Latin America Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027) Figure 48. Mexico Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Type (2016-2027) Figure 52. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Application (2016-2027) Figure 53. Middle East & Africa Prostate Cancer Diagnosis and Treatment Market Share by Country (2016-2027) Figure 54. Turkey Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 58. AbbVie Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 59. Active Biotech Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 60. Amgen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 61. Astellas Pharma Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 62. AstraZeneca Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 63. Bavarian Nordic Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 64. Bayer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 66. Dendreon Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 67. Endo Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 68. Ferring Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 69. GE Healthcare Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 70. GSK Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 71. Ipsen Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 72. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 73. Pfizer Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 74. Sanofi Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 75. Siemens Healthineers Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 76. Takeda Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 77. Teva Pharmaceutical Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 78. Tolmar Pharmaceuticals Revenue Growth Rate in Prostate Cancer Diagnosis and Treatment Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

Abbott Laboratories AbbVie Active Biotech Amgen Astellas Pharma AstraZeneca Bavarian Nordic Bayer Bristol-Myers Squibb Dendreon Endo Ferring Pharmaceuticals GE Healthcare GSK Ipsen Johnson & Johnson Pfizer Sanofi Siemens Healthineers Takeda Teva Pharmaceutical Tolmar Pharmaceuticals